期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺癌骨转移的治疗进展 被引量：3

暂未订购
导出
摘要 前列腺癌是唯一最先发生骨转移、而非内脏转移的实体肿瘤。骨转移在临床上十分常见 ,目前还缺乏有效的治疗手段。本文就前列腺癌骨转移近几年的治疗进展作一综述。
作者 杨全成 徐勇
机构地区 天津医科大学第二医院泌尿外科
出处 《国外医学（泌尿系统分册）》 2004年第2期153-157,共5页 Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
关键词 前列腺肿瘤 骨肿瘤 肿瘤转移
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Jemal A, Murray T, Sanmeles A, et al. Cancer Statistics. CA Cancer J Clin,2003,53,5 - 26.
  • 2Issaes Jr. The biology of hormone refractory prostate cancer. Why does it develop? Urol Clin North Am, 1999,26,263 - 273.
  • 3Bouchot O, lenormand L, Karam G, et al. Intermittent androgen suppression in the treatment of metastatic prostate cancer. Eur Urol,2000,38,543-549.
  • 4Tannock IF, Osoba D, Stockier MR, et al. Chemotherapy with mitoxantrone plus predniscne or predniscne alone for symptamatic hormone-resistant prostate cancer: a Cansdian randomized trial with palliative end points. J Clin Oncol, 1996,14,1756 - 1764.
  • 5Kantoff PW, Halabi S, Ccnaway M, et al. Hydrocortisone With or Without Mitoxantrone in Men With Honnone-Rehactory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study. J Clin Oncol, 1999, 17,2506-2513.
  • 6Hudes G, Einhom L, Ross E,et al. Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractary prostate cancer:a Hoosier Oncology Group and Fox Chase Network phase Ⅲ trial. J Clin Oncol, 1999,17,3160 - 3166.
  • 7Berry W, Gregurish M,Dakhil S,et al. Phase Ⅱ randomized trial of weekly paditaxel(Taxol(r) ) with or without estramustine phosphate in patients with symptomatic, hormone-refractary, metastatic prostate cancer. Proc Am Soc Clin Oncd, 2001,20,175a.
  • 8Hudes G, Ress E, Roth B, et al. Impovod survival for patients with hormone-refractory prostate cancer receiving estramustine-basse antimicrotubule therapy final report of a Homssier Oncology Group and Fox Chase Network,phase Ⅲ trial comparing viablastine and vinhlastine plus oral estyarmustine phosphate. Proc Am Soc Clin Oncol,2002,21,177a.
  • 9Hudes G, Manola J, Conroy T, et al. Phase Ⅱ study of weekly paclitaxel by 1-hour infusion plus reduced-dose oral estramustine in metastatic hormone-refractory prostate carcinoma. Proc Am Soc Clin Oncol, 2001,20,175a.
  • 10Small EJ, Bok R, Reese DM, et al. Docetaxel estramustine plus trastuzumab in patients with metastatic androgen-indent prostate cancer. Semin Oncol,2001,28(suppl 15) ,71 -76.

同被引文献22

引证文献3

二级引证文献7

国外医学（泌尿系统分册）
2004年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部